AI IntelligenceApr 12, 2026Secondary Market
Article
PFE
Bank of America lowers its price target on Pfizer to $26 from $27. The revision comes amid a reassessment of the product portfolio and pipeline. Analysts remain cautiously optimistic about long-term growth prospects.
Data Cube AI EditorialSource: Yahoo Finance
01
Source Brief
Bank of America lowers its price target on Pfizer to $26 from $27. The revision comes amid a reassessment of the product portfolio and pipeline. Analysts remain cautiously optimistic about long-term growth prospects.
02